CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Medy Tox Inc Company Snapshot
Medy Tox Inc operates within the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares Medy Tox Inc with three other companies in this sector in South Korea: Hugel Inc (2018 sales of 182.39 billion Korean Won [US$153.21 million] of which 51% was Toxins), Cell Biotech Co ., Limited. (62.54 billion Korean Won [US$52.54 million] of which 89% was Finished Products), and G-treeBNT Co Ltd (46.36 billion Korean Won [US$38.94 million] of which 61% was Medicine).

Sales Analysis. During the year ended December of 2018, sales at Medy Tox Inc were 205.44 billion Korean Won (US$172.57 million). This is an increase of 13.4% versus 2017, when the company's sales were 181.24 billion Korean Won. This was the fifth consecutive year of sales increases at Medy Tox Inc (and since 2013, sales have increased a total of 425%).
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Medy Tox Inc
  Stock Performance Chart for Medy Tox Inc
 
  Stock Data: Recent Stock Performance:
  Current Price (9/6/2019): 355,500
(Figures in Korean Won)
1 Week 1.0%   13 Weeks 4.5%  
4 Weeks -17.9%   52 Weeks -46.1%  
 
Medy Tox Inc Key Data:
  Ticker: 086900 Country: Korea (South)
  Exchanges: OTH Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2018 Sales 205,444,934,515
(Year Ending Jan 2019).
Employees: 280
  Currency: Korean Won Market Cap: 1,926,881,455,500
  Fiscal Yr Ends: December Shares Outstanding: 5,420,201
  Share Type: Common Closely Held Shares: 1,248,873
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.